Tuesday, May 24, 2022
ADVT 
National

Canadian trial suggests benefits of remdesivir

Darpan News Desk The Canadian Press, 19 Jan, 2022 02:28 PM
  • Canadian trial suggests benefits of remdesivir

A Canadian study suggests the antiviral medication remdesivir could have a "modest but significant effect" on COVID-19 patient outcomes, including decreasing the need for mechanical ventilation by approximately 50 per cent.

The study, published Wednesday in the Canadian Medical Association Journal, is billed as the largest single-country trial of remdesivir reported to date.

Results are part of a larger study called the World Health Organization Solidarity, a randomized, controlled trial evaluating remdesivir's impact on COVID-19 patients in several countries.

Researchers at the University of British Columbia and Sunnybrook Health Sciences Centre in Toronto recruited 1,282 patients at 52 hospitals between Aug. 14, 2020 and April 1, 2021. Roughly half received a 10-day course of remdesivir while the other half got the usual level of care.

Among participants not on ventilation at the start of the study, eight per cent of the remdesivir group — 46 patients — went on to require a ventilator compared to 15 per cent, or 89 patients, who received standard care.

The study also found patients on remdesivir came off oxygen and ventilators sooner.

Evidence has been mixed on the effect of remdesivir in people with COVID-19. The World Health Organization recommended against using it to treat the virus in November 2020, saying at the time "there is currently no evidence that remdesivir improves survival and other outcomes."

Remdesivir, which is administered intravenously, is a repurposed antiviral medication originally developed to treat hepatitis C.

Dr. Robert Fowler, a senior scientist at Sunnybrook and co-author of the study, said earlier recommendations against remdesivir stemmed from premature data that didn't show a statistically significant impact on COVID-19 patients.

He said the Canadian trial results could reverse opinions on the treatment, however.

"We'll probably help a number of other countries that have similar health-care systems in terms of resources to say: 'OK. ... (remdesivir) seems it has a number of positive effects," Fowler said.

"It will probably move the needle towards people having much more confidence the medication is effective for certain outcomes."

Fowler said he expects the WHO to release results from the Solidarity trial's other participating nations within the next couple of months.

The Canadian arm, funded by the Canadian Institutes of Health Research, collected more detailed data than some other countries and included patients across a range of ethnicities.

The study also looked at in-hospital mortality, which was slightly lower in the remdesivir group at 18.7 per cent, compared to 22.6 in the control group. Fowler said those figures weren't statistically significant "in absolute terms."

While the study period ended before Omicron arrived in Canada, Fowler said remdesivir is likely to have the same effect on those hospitalized with the variant.

He added that effective COVID-19 treatments are critical at this stage of the pandemic as soaring case counts have overwhelmed health-care systems across the country.

Publication of the study came two days after Health Canada authorized use of the take-home Pfizer antiviral pill Paxlovid, meant to reduce hospitalizations in those at higher risk of severe COVID-19 disease.

"It becomes critical that your next line of treatments are effective and growing," Fowler said.

"I would say, luckily, and with a lot of hard work behind it, there are an increasing number of medications, this one included ... to help patients survive and to get out of hospital sooner."

 

MORE National ARTICLES

B.C. doubles relief grants for certain businesses

B.C. doubles relief grants for certain businesses

A statement from the Ministry of Jobs, Economic Recovery and Innovation says businesses including event venues, bars, nightclubs and lounges that don't serve full meals are eligible for grants of up to $20,000, based on staffing levels.

B.C. doubles relief grants for certain businesses

Woman thrown against wall of hotel by attacker in Downtown: VPD

Woman thrown against wall of hotel by attacker in Downtown: VPD

The victim, a 22-year-old woman, was walking along West Georgia Street in front of Hotel Georgia when she was suddenly grabbed by a man, walking in the opposite direction, on December 31 at around 3:30 p.m. She was thrown against the exterior wall of the hotel and held down.

Woman thrown against wall of hotel by attacker in Downtown: VPD

Antiviral on its way to provinces and territories

Antiviral on its way to provinces and territories

Prime Minister Justin Trudeau says the first shipment of an oral COVID-19 pill is making its way across Canada but is no substitute for vaccination against the rapidly spreading virus. The anti-viral drug Paxlovid is meant to protect against hospitalization and death.

Antiviral on its way to provinces and territories

Unvaccinated military face uphill battle: lawyer

Unvaccinated military face uphill battle: lawyer

Controversy over mandatory vaccinations for the military has re-emerged during the pandemic, with chief of the defence staff Gen. Wayne Eyre ordering all personnel to be inoculated against COVID-19.

Unvaccinated military face uphill battle: lawyer

PBO report questions need for stimulus spending

PBO report questions need for stimulus spending

In a report this morning, Yves Giroux says the federal guardrails designed to guide spending decisions appear to have been met, suggesting any stimulus should be wound down before the fiscal year ends in March.

PBO report questions need for stimulus spending

Ship at 'high' readiness for NATO mission: admiral

Ship at 'high' readiness for NATO mission: admiral

Due to COVID-19 restrictions, families weren't permitted on the wharf in Halifax for the traditional sendoff as the HMCS Montreal pulled away from the jetty and its 240 crew members set off for the six-month deployment.

Ship at 'high' readiness for NATO mission: admiral

PrevNext